Europe Animal Health Market, By Vaccines

Growth Outlook

• The Europe Animal Health Market, By Vaccines market is on a steady long-term growth path. Segment value stands at roughly USD 3489 Mn in 2026 and is projected to reach USD 3777 Mn by 2027 — a gain of about 8% over the forecast period, translating to a CAGR in the high single digits.
• What the regional split looks like (2026): Live Attenuated Vaccines leads, holding roughly 65% of segment value — the single largest regional share. Inactivated Vaccines is the second-largest contributor. Recombinant Vaccines, DNA Vaccines and Others make up the remainder, in descending order.
• By 2027, Live Attenuated Vaccines alone is expected to reach USD 2473 Mn, with Inactivated Vaccines at USD 792 Mn.

Market Dynamics

Europe has always been at the forefront when it comes to animal health and welfare. With a strong awareness about the importance of animal health, the region has been investing heavily in developing innovative vaccines for the prevention and treatment of various diseases in animals. In fact, the Europe animal health market is one of the largest in the world, with a wide range of products and services being offered by numerous companies.

One of the key factors driving the demand for animal health vaccines in Europe is the growing livestock population. The region is home to a large number of livestock animals, including cattle, pigs, and poultry. These animals are vulnerable to a variety of diseases, which can not only impact their health but also affect the livelihoods of farmers and the overall economy. This has led to a high demand for vaccines that can provide effective protection against these diseases.

Another important factor contributing to the growth of the animal health market in Europe is the rise in pet ownership. With increasing disposable incomes and changing attitudes towards pets, more and more people are opting to have pets in their households. This has led to a surge in demand for animal health products and services, including vaccines, to keep their beloved companions healthy and disease-free.

Additionally, the strict regulations and guidelines set by the European Medicines Agency (EMA) on the use of antibiotics in animals has further increased the demand for vaccines. As the region aims to reduce the use of antibiotics in animals, there has been a shift towards preventive measures such as vaccinations to keep animals healthy and reduce the need for antibiotics.

Moreover, the increasing focus on food safety and quality has also boosted the demand for animal health vaccines in Europe. Consumers are becoming more conscious about the origin and safety of the food they consume, and this has led to a demand for healthy and disease-free animals. Vaccines play a crucial role in ensuring the health and well-being of animals, leading to safer and higher quality food products.

To cater to this growing demand, many animal health companies in Europe are investing in research and development to develop new and improved vaccines. This has resulted in the availability of a wide range of vaccines for different species and diseases, thereby driving the growth of the animal health market in Europe.

In conclusion, the increasing livestock population, rising pet ownership, strict regulations, and growing focus on food safety have all contributed to the high demand for animal health vaccines in Europe. As the region continues to invest in the development of innovative vaccines, the animal health market is expected to witness significant growth in the coming years.